SE445708B - Farmaceutiskt preparat innehallande ett kinazolinon och 5-klor-4-(2-imidazolin-2-yl-amino)-2,1,3-bensotiadiazol - Google Patents

Farmaceutiskt preparat innehallande ett kinazolinon och 5-klor-4-(2-imidazolin-2-yl-amino)-2,1,3-bensotiadiazol

Info

Publication number
SE445708B
SE445708B SE8002642A SE8002642A SE445708B SE 445708 B SE445708 B SE 445708B SE 8002642 A SE8002642 A SE 8002642A SE 8002642 A SE8002642 A SE 8002642A SE 445708 B SE445708 B SE 445708B
Authority
SE
Sweden
Prior art keywords
active
active substance
quinazolinone
chloro
imidazolin
Prior art date
Application number
SE8002642A
Other languages
English (en)
Swedish (sv)
Other versions
SE8002642L (sv
Inventor
D Romer
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH341179A external-priority patent/CH640415A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8002642L publication Critical patent/SE8002642L/xx
Publication of SE445708B publication Critical patent/SE445708B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8002642A 1979-04-10 1980-04-08 Farmaceutiskt preparat innehallande ett kinazolinon och 5-klor-4-(2-imidazolin-2-yl-amino)-2,1,3-bensotiadiazol SE445708B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH341179A CH640415A5 (en) 1979-04-10 1979-04-10 Therapeutic preparations for the treatment of pain
CH340979 1979-04-10

Publications (2)

Publication Number Publication Date
SE8002642L SE8002642L (sv) 1980-10-11
SE445708B true SE445708B (sv) 1986-07-14

Family

ID=25692937

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8002642A SE445708B (sv) 1979-04-10 1980-04-08 Farmaceutiskt preparat innehallande ett kinazolinon och 5-klor-4-(2-imidazolin-2-yl-amino)-2,1,3-bensotiadiazol

Country Status (18)

Country Link
US (1) US4442084A (fr)
AR (1) AR228255A1 (fr)
AU (1) AU538643B2 (fr)
CA (1) CA1147261A (fr)
DE (1) DE3012837A1 (fr)
ES (1) ES8105148A1 (fr)
FR (1) FR2453648A1 (fr)
GB (1) GB2047534B (fr)
HU (1) HU183119B (fr)
IE (1) IE49676B1 (fr)
IL (1) IL59786A (fr)
IT (1) IT1143133B (fr)
MY (1) MY8500127A (fr)
NL (1) NL8002041A (fr)
NZ (1) NZ193379A (fr)
PH (1) PH17681A (fr)
PT (1) PT71066A (fr)
SE (1) SE445708B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2499991A1 (fr) * 1981-02-19 1982-08-20 Sandoz Sa Nouveaux 2,1,3-benzothiadiazoles et 2,1,3-benzoxadiazoles, leur preparation et leur application comme medicaments
GB8306473D0 (en) * 1983-03-09 1983-04-13 Sandoz Ltd Analgesic preparations
GB2135884B (en) * 1983-03-09 1986-09-17 Sandoz Ltd Analgesic preparations containing tizanidine and paracetamol
JPS608274A (ja) * 1983-06-27 1985-01-17 Fujisawa Pharmaceut Co Ltd 新規キナゾリノン誘導体およびその製造法・並びに抗アレルギ−剤
HUT47849A (en) * 1986-11-03 1989-04-28 Sandoz Ag Process for producing new pharmaceutical with analgetic and hypertonicity-relaxing effect
DE3738844A1 (de) * 1987-11-16 1989-05-24 Merck Patent Gmbh Analgetikum
US5039999A (en) * 1990-06-26 1991-08-13 Hewlett-Packard Company Accumulator and pressure control for ink-ket pens
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
US20050089559A1 (en) * 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG16442A3 (bg) * 1967-10-30 1972-11-20 Max Denzer Метод за получаване на нови о-изопропиламинобензофенони
CH569722A5 (fr) * 1971-06-24 1975-11-28 Sandoz Ag
US3759920A (en) * 1971-06-24 1973-09-18 Sandoz Ag Process for the preparation of 1-substituted-phenyl-2(1h)-quinazolinones
BE801898A (fr) * 1973-07-04 1974-01-04 Merck Patent Gmbh Procede de preparation de produits pharmaceutiques pour le traitement de l'insomnie.

Also Published As

Publication number Publication date
IL59786A0 (en) 1980-06-30
DE3012837A1 (de) 1980-10-30
MY8500127A (en) 1985-12-31
US4442084A (en) 1984-04-10
IL59786A (en) 1984-02-29
NZ193379A (en) 1984-07-31
PH17681A (en) 1984-11-02
IE800724L (en) 1980-10-10
ES490453A0 (es) 1981-05-16
SE8002642L (sv) 1980-10-11
FR2453648A1 (fr) 1980-11-07
AR228255A1 (es) 1983-02-15
AU5722380A (en) 1980-10-16
GB2047534B (en) 1983-04-20
NL8002041A (nl) 1980-10-14
IE49676B1 (en) 1985-11-27
HU183119B (en) 1984-04-28
ES8105148A1 (es) 1981-05-16
FR2453648B1 (fr) 1983-06-24
AU538643B2 (en) 1984-08-23
IT1143133B (it) 1986-10-22
IT8048364A0 (it) 1980-04-08
CA1147261A (fr) 1983-05-31
GB2047534A (en) 1980-12-03
PT71066A (en) 1980-05-01

Similar Documents

Publication Publication Date Title
ES2175385T5 (es) Combinacion farmaceutica que contiene un compuesto que tiene actividad antagonista de angiotensina ii y un compuesto que aumenta la sensibilidad a la insulina.
ES2288631T3 (es) Nuevo ligando ppar que no causa retencion de fluidos, edema o insuficiencia cardiaca congestiva.
US20110172251A1 (en) Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
JPH07509456A (ja) ２型糖尿病および肥満の治療および予防のための１，３−ジシクロプロピメチル−８−アミノ−キサンチンの使用
CA2601509A1 (fr) Ligand du recepteur nicotinique neuronal alpha7 et compositions antipsychotiques
SE445708B (sv) Farmaceutiskt preparat innehallande ett kinazolinon och 5-klor-4-(2-imidazolin-2-yl-amino)-2,1,3-bensotiadiazol
EP0351733B1 (fr) Utilisation de dérivés de 2,3,4,5-tétrahydro-1H-3-benzazépines dans le traitement de troubles neurologiques
US4208417A (en) Indole derivatives and their use as anxiolytics
SK15472001A3 (sk) Použitie saredutantu a jeho farmaceuticky prijateľných solí na prípravu liečiva použiteľného na liečenie alebo prevenciu porúch nálady, porúch adaptácie alebo stavov úzkosti a depresie
US20060025448A1 (en) Hair growth stimulators
EP0345931B1 (fr) Certains mélanges PAF antagonistes/antihistamine et procédés
ITRM940322A1 (it) "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione ed applicazione".
JPH0240665B2 (fr)
US5334592A (en) Certain PAF antagonist antihistamine combinations and methods
EP2146714B1 (fr) Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des desordres moteurs lies a la maladie de parkinson
EP0437025A2 (fr) Compositions contenant des inhibiteurs de l'aldose réductase pour le traitement des ulcères
FR2544614A1 (fr) Nouvelle association medicamenteuse pour le traitement de l'hypertension
SK227092A3 (en) Pharmaceutical agent against the high blood pressure
US4329354A (en) Thiazoline and imidazoline derivatives useful as antidepressants
KR960005145B1 (ko) 고혈압 및 울혈성 심부전증 치료용 약학적 조성물
NL9000158A (nl) Samenstelling van benazepril/thiazidediureticum in lage dosering.
HU181913B (en) Process for preparing synergetic pharmaceutical composition with skeleton muscle relaxing activity
CA1331568C (fr) Composition pharmaceutique contenant du dihydropyridine-dianhydrohexitol et un derive nitre
CN101594868B (zh) 具有抗精神病、抗抑郁或抗癫痫活性以及较小副作用的药物组合物
US4039674A (en) 3-(3-Methyl-2-octyl)-1-[4-(1-homopiperidine)butyryloxy]-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-dibenzo [b,d]pyran hydrochloride as an anticonvulsant agent

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8002642-0

Effective date: 19911108

Format of ref document f/p: F